Covaxin gets DGCI`s approval for use among children above 12 years with certain conditions

https://ift.tt/2gKvzPo is the second vaccine to receive the regulator's nod for use among those below 18 years after Zydus Cadila's needle-free COVID-19 vaccine ZyCoV-D.

from Zee News :India National https://ift.tt/3HcGqJT
via IFTTT